PRODUCT EVIDENCE JOURNAL · 06 / 10
2.00% in 3F, 5.00% in Tone-Up: why concentration is not a finished-product score
The niacinamide numbers are useful formula details. They are not a shortcut for calculating which ampoule will work better on your skin.
NARINFLA JOURNAL · PRODUCT EVIDENCE SERIES

Official product photograph; not a study image.
On this page
What does the difference between 2.00% and 5.00% mean?Which evidence belongs to each complete formula?Can published ingredient research fill the gap?Does a percentage tell you whether a formula suits you?What should the product comparison help you decide?- Domestic 3F ingredient information lists 2.00% niacinamide; Repair Tone-Up lists 5.00%.
- A concentration ratio is not an efficacy ratio, and these ampoules were not compared in one controlled trial.
- Read the complete product, its matching report and your tolerance together.
What does the difference between 2.00% and 5.00% mean?
narinfla Lifting Booster 3F Ampoule
Niacinamide 2.00%
narinfla Repair Tone-Up Ampoule
Niacinamide 5.00%
Ingredient concentrations are not finished-product efficacy scores.
It means that the products’ reported niacinamide concentrations differ. Five divided by two is 2.5, but that arithmetic does not make Tone-Up 2.5 times more effective than 3F. Concentration and a measured product outcome are different quantities.
The domestic 50 ml 3F formula contains 2.00% niacinamide and 0.04% adenosine, together with EGF, FGF, IGF and 11 peptides. Repair Tone-Up ingredient information reports niacinamide 5.00% and includes tranexamic acid without a verified concentration here.
This is a comparison of two complete formulas, not a controlled experiment changing only niacinamide. Many other characteristics differ, so we should not assign any difference in the products’ reports to that single concentration change.
Which evidence belongs to each complete formula?
The finished-product reports belong to their tested products or samples and their own endpoints. The domestic 3F four-week wrinkle study involved 20 women, average age 50, and reported mean changes in under-eye, nasolabial and neck measurements.
The 2026 Tone-Up pigmentation report involved 20 women and a two-week observation period. Its 27.4% mean change in facial pigmentation area belongs to submitted sample PM-26SA-947 in report PM-26J26-ML085; its identity with the currently sold Repair Tone-Up Ampoule has not been established.
The 3F wrinkle outcomes and Tone-Up pigmentation outcome are not two entries on the same scorecard. Neither proves that its niacinamide concentration is universally better for every concern or that one formula’s result transfers to the other.
How much of a named ingredient is reported in the formula. It does not describe the outcome of a person’s use.
A defined measurement obtained for a particular tested product or sample, population and observation period.
Related evidence: Reading the 3F numbers: the average is not the best individual result. Official product ingredients and study information.
Can published ingredient research fill the gap?
Published ingredient research can provide context, but it cannot turn these two ampoules into a head-to-head trial. To support a finished-product statement, the research must be relevant to the formulation, claim and use conditions.
The Claims Sub-Working Group’s technical guidance makes this distinction explicit: ingredient properties should not imply properties of the finished product without adequate evidence. That is a useful reading principle, not a claim that narinfla has regulatory approval in another market.
We therefore avoid borrowing a percentage from a niacinamide paper and placing it beside the bottle as a narinfla result. We also do not assume that a higher concentration must produce more benefit, less comfort or a predictable irritation rate for every user.
Does a percentage tell you whether a formula suits you?
Not on its own. Your response concerns the complete formula, its directions and your skin, rather than one number in isolation. A concentration is a useful fact to consider, but it does not diagnose your needs or guarantee tolerance.
The 3F patch-test record is a separate tolerability observation. Its favorable result cannot be assigned exclusively to niacinamide, and it cannot be used as proof that every higher- or lower-concentration product will behave identically.
If you are using several products, consider that their ingredient lists may overlap. The reports described here do not test every possible combination, and a simple calculation adding their percentages would not describe actual skin exposure or benefit.
What should the product comparison help you decide?
narinfla Lifting Booster 3F Ampoule
Niacinamide 2.00%
narinfla Repair Tone-Up Ampoule
Niacinamide 5.00%
Ingredient concentrations are not finished-product efficacy scores.
It should help you identify the concern, formula information and evidence that matter to you. For 3F, the domestic wrinkle study offers a defined four-week observation. For Tone-Up, the pigmentation sample study offers a different observation with a clear sample-identity limit.
Read those reports beside the product directions rather than turning the niacinamide percentages into a league table. If you have a specific sensitivity or active skin problem, seek advice appropriate to that concern instead of choosing by concentration alone.
A brand can explain why formulas differ without claiming one is superior. The useful distinction is not “strong versus weak” but “different complete products, with different supporting records and different questions.”
Keeping that distinction visible also prevents a familiar ingredient from carrying more evidence than it actually has. Two clear percentages can be informative without becoming a promise.
Questions & answers
Is Tone-Up 2.5 times more effective because it lists 5.00% niacinamide?
No. The concentration ratio is 2.5, but no corresponding finished-product efficacy ratio is established.
Can 3F’s tolerability result predict my response to Tone-Up?
No. Tolerability records are product-specific, and individual responses to a complete formula can differ.
Were the two complete formulas tested in one direct comparison?
The supplied records describe separate studies with different endpoints. They do not establish a head-to-head efficacy comparison between these ampoules.
Sources and scope
- ProBM domestic 3F wrinkle study, 2023PM-23A29-WR008
Brand-held human application report: 20 women, average age 50 years, four weeks; under-eye, nasolabial and neck outcomes. Full report is not publicly linked here.
- ProBM pigmentation study, 2026PM-26J26-ML085; test sample PM-26SA-947
Brand-held report, 20 women, two weeks. The result concerns submitted sample PM-26SA-947; its identity with the currently sold Repair Tone-Up Ampoule has not been established.
- Technical document on cosmetic claims, Claims Sub-Working Group, 3 July 2017, Annexes I–II
Non-binding best-practice guidance on relevant evidence, product identity, study conditions and avoiding exaggerated interpretations; not a narinfla trial or European Commission legal ruling.
- narinfla official English product information
Official brand hub; consult the corrected version for product-specific information. Not a public archive of the full clinical reports.
Related reading
Read the official product facts →Information only. Follow the current package directions. Cosmetics do not replace diagnosis or treatment.